ESC 365 - CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality

ESC Premium Access

CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality

Session: Clinical Trial Updates

Topic: Treatment

Speaker: Doctor P. Ridker (Boston, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

37 presentations

7 followers

11 more presentations in this session

COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Discussant review - COMPASS.

Speaker: Professor L. Wallentin (Uppsala, SE)

Discussant review - CANTOS.

Speaker: Professor M. Packer (Dallas, US)

CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation

Speaker: Professor J. Poole (Seattle, US)

Discussant review - CABANA.

Speaker: Professor C. Leclercq (Rennes, FR)

Access the full session

Clinical Trial Updates

Speakers: Doctor P. Ridker, Doctor J. Eikelboom, Professor L. Wallentin, Professor M. Packer, Professor J. Poole...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources